Corporate Disclosure Principles Signaled In SEC/British Biotech Settlement
Executive Summary
The Securities & Exchange Commission could use its recent ruling that a "cease and desist" settlement appropriately addresses misleading statements made by British Biotech as precedent for corporate disclosure principles.